Risk Factors and Management of Portal Vein Thrombosis after Hepatectomy: A Single-Center Experience
Objective:. This study investigated the risk factors and management of portal vein thrombosis (PVT) after hepatectomy. Background:. PVT after hepatectomy can cause liver dysfunction and portal hypertension, and may be fatal. However, it has not been sufficiently investigated. Methods:. The study inc...
Saved in:
Main Authors: | Kazuki Wakizaka, MD, PhD, Shunsuke Shichi, MD, Takeshi Aiyama, MD, PhD, Yoh Asahi, MD, PhD, Akihisa Nagatsu, MD, PhD, Tatsuya Orimo, MD, PhD, Tatsuhiko Kakisaka, MD, PhD, Akinobu Taketomi, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2024-12-01
|
Series: | Annals of Surgery Open |
Online Access: | http://journals.lww.com/10.1097/AS9.0000000000000523 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma
by: Yuji Uehara, MD, et al.
Published: (2025-03-01) -
Comment on Portal Hemodynamics in Liver Transplantation: Do not Shunt The Large-For-Flow!
by: Xavier Muller, MD, PhD, et al.
Published: (2024-06-01) -
Lumbosacral Plexopathy After Carbon-ion Radiation Therapy for Postoperative Pelvic Recurrence of Rectal Cancer: Subanalysis of a Prospective Observational Study (GUNMA 0801)
by: Takuya Kumazawa, MD, PhD, et al.
Published: (2025-03-01) -
EGFR-Mutated Lung Adenocarcinoma With Li–Fraumeni Syndrome: The Imperative for Germline Testing in Patients With a Family History, a Case Report
by: Hiroyuki Fujii, MD, et al.
Published: (2025-02-01) -
Elevated mepolizumab levels in patients with severe asthma responsive to 1 year’s mepolizumab treatment
by: Takayasu Nishimaki, MD, et al.
Published: (2025-05-01)